Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about IONS

Recent news which mentions IONS

< Previous 1 2 3 4 5 6 Next >
Analyst Upgrades Ionis Pharmaceuticals To Buy Amid Key Pipeline Developments: Eplontersen And Donidalorsen Show Promising Outlook
Tickers ALNY AZN IONS
Tags Briefs Equities Market News
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For July 31, 2023
Tickers A ABR ADBE AIV
Tags Initiation AMAM CVX
From Benzinga
Apple To Rally Over 12%? Here Are 10 Other Analyst Forecasts For Monday
Tickers AAPL ADBE BAX CMCSA
Tags GTLS ADBE IONS
From Benzinga
Biogen Reports New Spinraza Data In Atrophy Patients After Incomplete Response To Novartis' Treatment
Tickers BIIB IONS NVS
Tags Biotech IONS BIIB
From Benzinga
Hereditary Angioedema Update Solidifies Intellia's Cell Therapy's Competitive Efficacy Profile: Analyst
Tickers IONS NTLA
Tags Expert Ideas Biotech IONS
From Benzinga
Analyst Creates Bullish Pitch On Ionis Pharmaceuticals Citing 'Strategic Pivot Underway'
Tickers AZN IONS
Tags Health Care News Trading Ideas
From Benzinga
Why Ionis Pharmaceutical Shares Are Trading Lower Wednesday
Tickers IONS
Tags Market News why it's moving News
From Benzinga
Analyst Expectations for Ionis Pharmaceuticals's Future
Tickers IONS
Tags Market News Analyst Ratings BZI/AAR
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For May 4, 2023
Tickers ABSI BLDR BLKB CERE
Tags CX IONS PCOR
From Benzinga
Recap: Ionis Pharmaceuticals Q1 Earnings
Tickers IONS
Tags IONS BZI/Recaps Benzinga
From Benzinga
Ionis Pharmaceuticals's Earnings Outlook
Tickers IONS
Tags IONS Benzinga Earnings
From Benzinga
Biogen's Amyotrophic Lateral Sclerosis Drug Scores Conditional Approval From FDA
Tickers BIIB IONS
Tags Large Cap News General
From Benzinga
FDA grants accelerated approval to Biogen treatment for rare form of ALS
Tickers BIIB IONS
Tags BIIB IONS
From MarketWatch
What's Going On With Biogen Stock Tuesday?
Tickers BIIB IONS
Tags Movers FDA Earnings
From Benzinga
Biogen Announces Additional Cost Cutting Initiatives, Chops Certain Stroke, Gene Therapy Programs
Tickers BIIB IONS
Tags Briefs Guidance Biotech
From Benzinga
3 Biotech Stocks to Sell Before They’re 6 Feet Under
Tickers ACRS AMRS IONS
Tags NASDAQ:AMRS,NASDAQ:ACRS,NASDAQ:IONS Market News AMRS
From InvestorPlace
AstraZeneca, Ionis Unveil Complete Phase 3 Data For ATTR Candidate, Says Drug Halts Disease Progression
Tickers AZN AZNCF IONS
Tags AZNCF Health Care IONS
From Benzinga
Could This Rare-Disease Drug Candidate Become a Blockbuster?
Tickers AZN IONS
Tags AZN Market News IONS
From Motley Fool
Analyst Upgrades Arrowhead Pharma Citing 'Attractive Risk/Reward'
Tickers ALNY ARWR IONS MRNA
Tags Analyst Color Health Care News
From Benzinga
Analyst Expectations for Ionis Pharmaceuticals's Future
Tickers IONS
Tags Benzinga IONS BZI/AAR
From Benzinga
AstraZeneca-Ionis Partnered Rare Disease Drug Data Shows Sustained Benefit; Drug Under FDA Review
Tickers AZN AZNCF BXRX IONS
Tags AZN Biotech Market News
From Benzinga
FDA Adcomm Says Benefit-Risk Profile Favor Biogen's Tofersen For Inherited Neuro Disorder
Tickers BIIB IONS
Tags News General Benzinga
From Benzinga
Analyst Ratings for Ionis Pharmaceuticals
Tickers IONS
Tags Benzinga IONS BZI/AAR
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For March 21, 2023
Tickers ADC AIZ ALLO ALNY
Tags BEAM NTLA RAIN
From Benzinga
Wall Street predicts approval for another ALS drug
Tickers AMLX BIIB IONS
Tags JP:4523 AMLX BIIB
From MarketWatch
Biogen Triumphs In Legal Battle Regarding Tecfidera, Delaying EU Generic Erosion For Another Year
Tickers BIIB IONS
Tags Trading Ideas News Large Cap
From Benzinga
Ionis Pharmaceuticals's Earnings Outlook
Tickers IONS
Tags Market News BZI/EP Earnings
From Benzinga
Analyst Says Ionis' Additional Hereditary Angioedema Study Data Supports 'Highly Competitive Profile'
Tickers IONS
Tags General News Analyst Ratings
From Benzinga
Analyst Expectations for Ionis Pharmaceuticals's Future
Tickers IONS
Tags Benzinga IONS BZI/AAR
From Benzinga
EXAS Nears Key Buy Signal in Active Biotech ETF ARKG
Tickers ARKG EXAS IONS PACB
Tags IONS ARKG active biotech ETF
From ETF Trends
< Previous 1 2 3 4 5 6 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.